ReviewLeukemia2022
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Erratum issued 4 registry-linked trialsOpen access · hybridAbstract readReview
In one paragraph
Review in Leukemia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 4 registered trials, which are not on this map. Cited by 2,246 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
2,246citing papers in PubMed, 3 pooled it
472.3field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Phase 1 Study to Evaluate the Safety and Preliminary Efficacy of ATA3219, Allogeneic Anti-CD19 Chimeric Antigen Receptor T-cell Therapy, in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Immunophenotypic Evaluation of Inhibitory Immune Receptors CD305 and CD85d in B-Cell Lymphoid Neoplasms
Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma Across the Military Healthcare System
BRIDGE-NK: A Randomized, Open-Label, Prospective Phase III Study of Immunotherapy Induction Versus Chemotherapy Induction Followed by Autologous Hematopoietic Stem Cell Transplantation Consolidation in Newly Diagnosed Advanced Extranodal NK/T-Cell Lymphoma
Who cites it
2,246 citing papers in PubMed, 3 syntheses or guidelines pooled it, 3,466 citations in OpenAlex.
- International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026Guideline
- Cellular therapy in mantle cell lymphoma: recommendations from the EBMT practice harmonisation and guidelines committee.Bone marrow transplantation · 2026Guideline
- Clinical utility of cerebrospinal fluid interleukin-10 in central nervous system lymphoma: a molecular neuropathology-informed diagnostic meta-analysis.Journal of molecular medicine (Berlin, Germany) · 2026Pooled it
- Selinexor combined with R-CHOP achieved a high response rate in newly diagnosed double/triple-hit lymphoma.Blood advances · 2026Trial
- Liposomal mitoxantrone plus tislelizumab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma: a phase 1b/2 trial.Nature communications · 2026Trial
- Case Report of a Rapidly Progressive Indolent T-Cell Lymphoma of the Gastrointestinal Tract.DEN open · 2027Article
- Successful Endoscopic Submucosal Dissection for Primary Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma.DEN open · 2027Article
- Clinical Flow Cytometric Testing in Chronic Lymphocytic Leukemia.Methods in molecular biology (Clifton, N.J.) · 2027Article
- Epidemiology and outcomes of invasive fungal infections in patients with mature T-cell and NK-cell lymphomas.Annals of medicine · 2026Article
- Breast implant-associated diffuse large cell B-cell lymphoma (BIA-DLBCL) - a case report and a treatment algorithm.JPRAS open · 2026Article
- SuperRCA assay ofThe journal of allergy and clinical immunology. Global · 2026Article
- Pediatric Mediastinal Gray Zone Lymphoma With Germline TET2 Heterozygous Variant.Pediatric blood & cancer · 2026Article
- Genomic architecture of IRF4 rearrangements in childhood and adult large B-cell lymphomas.Blood advances · 2026Article
- Clinical outcomes, patterns of relapse, and molecular landscape of advanced stage high-grade B-cell lymphoma.Blood advances · 2026Article
- The GMALL B ALL/NHL 2002 protocol yields high rates of durable response in high grade B cell lymphoma.Blood cancer journal · 2026Article
- Beyond MYD88-only testing: MYD88/CD79B profiling improves molecular detection and MCD genotyping in VRL and CNS lymphomas.Experimental hematology & oncology · 2026Article
- Post-treatment residual masses in orbital lymphoma: incidence, risk factors, and prognostic impact.Eye (London, England) · 2026Article
- Targeting CD28 on T lineage malignancies with chimeric antigen receptor T cells.Nature communications · 2026Article
- Article
- Genomic Medicine Sweden: Advancing precision medicine at the national level.Journal of internal medicine · 2026Review
2,186 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
- Erratum issued
Authors and funding
83 authors at 20 institutions in 16 countries.
Rita AlaggioPathology Unit, Department of Laboratories, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0003-3915-3816
Catalina AmadorDepartment of Pathology, University of Miami, Miami, FL, USA.ORCID http://orcid.org/0000-0003-0352-5526
Ioannis AnagnostopoulosInstitute of Pathology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0002-5043-6043
Ayoma D AttygalleDepartment of Histopathology, Royal Marsden Hospital, London, UK.ORCID http://orcid.org/0000-0001-5034-8150
Iguaracyra Barreto de Oliveira AraujoDepartment of Pathology, Federal University of Bahia (UFBA), Salvador, Brazil.
Emilio BertiUniversity of Milan, Fondazione Cà Granda, IRCCS, Ospedale Maggiore Policlinico, Milan, Italy.ORCID http://orcid.org/0000-0001-6753-4910
Govind BhagatDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-6250-048X
Anita Maria BorgesDivision of Histopathology, SL Raheja Hospital, Mumbai, India.
Daniel BoyerDepartment of Pathology, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0001-9948-3193
Mariarita CalaminiciCentre for Haemato-Oncology, Barts Cancer institute, QMUL and SIHMDS Barts Health NHS Trust, London, UK.ORCID http://orcid.org/0000-0003-4094-1633
Amy ChadburnDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-9499-8638
John K C ChanDepartment of Pathology, Queen Elizabeth Hospital, Kowloon, Hong Kong.ORCID http://orcid.org/0000-0001-5068-6707
Wah CheukDepartment of Pathology, Queen Elizabeth Hospital, Kowloon, Hong Kong.ORCID http://orcid.org/0000-0003-3160-9591
Wee-Joo ChngNational University Cancer Institute, Singapore, Singapore.ORCID http://orcid.org/0000-0003-2578-8335
John K ChoiDepartment of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID http://orcid.org/0000-0002-2861-0180
Shih-Sung ChuangDepartment of Pathology, Chi-Mei Medical Center, Tainan, Taiwan.ORCID http://orcid.org/0000-0003-3971-525X
Sarah E CouplandLiverpool Clinical Laboratories, Liverpool University Hospitals Foundation Trust, Liverpool, UK.ORCID http://orcid.org/0000-0002-1464-2069
Magdalena CzaderDepartment of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN, USA.ORCID http://orcid.org/0000-0002-6173-6500
Sandeep S DaveCenter for Genomic and Computational Biology and Department of Medicine, Duke University, Durham, NC, USA.ORCID http://orcid.org/0000-0003-4848-9768
Daphne de JongAmsterdam UMC, location Vrije Universiteit Amsterdam, Department of Pathology, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-9725-4060
Ming-Qing DuDivision of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK. mqd20@cam.ac.uk.ORCID http://orcid.org/0000-0002-1017-5045
Kojo S Elenitoba-JohnsonDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-1082-1545
Judith FerryDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. JFERRY@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-3428-4166
Julia GeyerDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-4424-6139
Dita GratzingerDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-9182-8123
Joan GuitartDepartment. of Dermatology, Northwestern University Feinberg Medical School, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-7635-9237
Sumeet GujralDepartment of Pathology, Tata Memorial Hospital, Mumbai, India.ORCID http://orcid.org/0000-0001-8648-1172
Marian HarrisDepartment of Pathology, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9956-664X
Christine J HarrisonTranslational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle-upon-Tyne, UK.ORCID http://orcid.org/0000-0002-0526-6794
Sylvia HartmannDr. Senckenberg Institute of Pathology, Goethe University Frankfurt, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0003-3424-1091
Andreas HochhausHematology/Oncology, Universitätsklinikum Jena, Jena, Germany.ORCID http://orcid.org/0000-0003-0626-0834
Patty M JansenLeiden University Medical Center, Department of Pathology, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-2361-9303
Kennosuke KarubeDepartment of Pathology and Laboratory Medicine, Nagoya, Japan.
Werner KempfKempf und Pfaltz Histologische Diagnostik Zurich, and Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-6552-8629
Joseph KhouryDepartment of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-2621-3584
Hiroshi KimuraDepartment of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID http://orcid.org/0000-0001-8063-5660
Wolfram KlapperDepartment of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.ORCID http://orcid.org/0000-0001-7208-4117
Alexandra E KovachDepartment of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-6742-6749
Shaji KumarDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-5392-9284
Alexander J LazarDepartments of Pathology & Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-6395-4499
Stefano LazziDepartment of Medical Biotechnology, University of Siena, Siena, Italy.ORCID http://orcid.org/0000-0002-2218-3771
Lorenzo LeonciniDepartment of Medical Biotechnology, University of Siena, Siena, Italy.ORCID http://orcid.org/0000-0002-7457-300X
Nelson LeungDivision of Nephrology and Hypertension, Division of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-5651-1411
Vasiliki LeventakiDepartment of Pathology, Medical College of Wisconsin and Children's Wisconsin, Milwaukee, WI, USA.ORCID http://orcid.org/0000-0003-1145-3550
Xiao-Qiu LiDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.ORCID http://orcid.org/0000-0002-8758-2191
Megan S LimDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-0415-2867
Wei-Ping LiuDepartment of Pathology, West-China Hospital, Sichuan University, Chengdu, China.ORCID http://orcid.org/0000-0002-6819-5612
Abner LouissaintDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-6707-917X
Andrea MarcoglieseDepartment of Pathology & Immunology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.ORCID http://orcid.org/0000-0002-1458-9675
L Jeffrey MedeirosDepartment of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-6577-8006
Michael MichalDepartment of Pathology, Charles University in Prague, Faculty of Medicine in Plzen, Plzen, Czech Republic.ORCID http://orcid.org/0000-0003-4403-7027
Roberto N MirandaDepartment of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-8467-5464
Christina MitteldorfDepartment of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.ORCID http://orcid.org/0000-0002-0971-0370
Santiago Montes-MorenoAnatomic Pathology Department and Translational Hematopathology Lab, Valdecilla/IDIVAL University Hospital, Santander, Spain.ORCID http://orcid.org/0000-0002-3565-8262
William MoriceDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-5801-2501
Valentina NardiDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-0486-416X
Kikkeri N NareshSection of Pathology, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0003-3807-3638
Yasodha NatkunamDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-9816-1018
Siok-Bian NgDepartment of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0001-6051-6410
Ilske OschliesDepartment of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.ORCID http://orcid.org/0000-0002-4003-6855
German OttDepartment of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany. German.Ott@rbk.de.ORCID http://orcid.org/0000-0001-7990-6793
Marie ParrensDepartment of Pathology, Bordeaux University Hospital, Bordeaux, France.ORCID http://orcid.org/0000-0002-4335-4138
Melissa PulitzerDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-0606-9186
S Vincent RajkumarDivision of Hematology, Mayo Clinic, Rochester, Minnesota, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-5862-1833
Andrew C RawstronHMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.ORCID http://orcid.org/0000-0003-0798-9790
Karen RechDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-6770-2339
Andreas RosenwaldInstitute of Pathology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0001-7282-8374
Jonathan SaidDepartment of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-9474-2563
Clémentine SarkozyMD-PhD, DITEP, Gustave Roussy, Villejuif, France.ORCID http://orcid.org/0000-0002-1942-9304
Shahin SayedDepartment of Pathology- Aga Khan University Hospital- Nairobi, Nairobi, Kenya.ORCID http://orcid.org/0000-0002-3472-511X
Caner SayginSection of Hematology/Oncology, University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-7617-8356
Anna SchuhDepartment of Oncology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-3938-8490
William SewellImmunology Division, Garvan Institute of Medical Research, Sydney, Australia.ORCID http://orcid.org/0000-0002-3586-8761
Reiner SiebertInstitute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany. reiner.siebert@uni-ulm.de.ORCID http://orcid.org/0000-0002-6492-5323
Aliyah R SohaniDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6307-4854
Reuben ToozeDivision of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0003-2915-7119
Alexandra Traverse-GlehenHospices Civils de Lyon/Department of Pathology/ Université Lyon 1/ Centre International de Recherche en Infectiologie (CIRI) INSERM U1111 -, CNRS UMR5308, Lyon, France.ORCID http://orcid.org/0000-0002-3934-0120
Francisco VegaDepartment of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-5956-452X
Beatrice VergierDepartment of Pathology, Hopital Haut-Lévêque, CHU Bordeaux, Pessac, France.ORCID http://orcid.org/0000-0002-3498-3143
Ashutosh D WechalekarNational Amyloidosis Centre, University College London, London, UK.ORCID http://orcid.org/0000-0002-4406-7237
Brent WoodDepartment of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Luc XerriDepartment of Pathology, Institut Paoli-Calmettes and Aix-Marseillreference University, Marseille, France.ORCID http://orcid.org/0000-0002-8672-9921
Wenbin XiaoDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-8586-8500
The University of Texas MD Anderson Cancer Center · USHarvard University · USMayo Clinic in Arizona · USChildren's Hospital of Los Angeles · USCornell University · USMemorial Sloan Kettering Cancer Center · USQueen Elizabeth Hospital · CNStanford University · USUniversity Hospital Schleswig-Holstein · DEUniversity of Pennsylvania · USUniversity of Siena · ITUniversity of Würzburg · DEAga Khan University Hospital Nairobi · KEAmsterdam University Medical Centers · NLBambino Gesù Children's Hospital · ITBarts Health NHS Trust · GBBaylor College of Medicine · USBoston Children's Hospital · USCharles University · CZChildren's Hospital of Wisconsin · US
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4MAssessing lineage infidelity, oncogenic cooperativity and dependency in RUNX1-mutant acute myeloid leukemiaK08CA267058 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI XIAO, WENBIN · 2022 to 2025
$1.1MNCI NIH HHS K08 CA267058NCI NIH HHS P30 CA008748
Abstract
We herein present an overview of the upcoming 5
Indexed as
Hematologic NeoplasmsLymphomaHumansWorld Health Organization
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
NCT06256484ClinicalTrials.gov
NCT07499635ClinicalTrials.gov
NCT07652580ClinicalTrials.gov
NCT07678229ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.